🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Bioavailability is the extent and rate to which the active drug ingredient ...
Status
Unknown
Location
Department of Pharmacy, Kathmandu University
Start Date
2023-08-06
Trial ID
NCT05641649
Treatments Being Tested
The main objectives of this trial are to investigate safety and tolerabilit...
Status
Completed
Location
SOUSEIKAI Sumida Hospital
Start Date
2021-08-05
Trial ID
NCT04958252
Treatments Being Tested
Dolutegravir (DTG) and lamivudine (3TC) are indicated in combination with o...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-05
Trial ID
NCT02738931
The aim of the study is to determine glycemic and insulinemic index of 2 sw...
Status
Unknown
Location
Biofortis
Start Date
2011-02
Trial ID
NCT01343797
The objective of the study is to compare the bioavailability of the Test an...
Status
Completed
Location
QUINTA-ANALYTICA s.r.o.
Start Date
2019-06-25
Trial ID
NCT05124717
Comparative, Randomized, Single Dose, Two-way Crossover Bioequivalence Stud...
Status
Completed
Location
Genuine Research Center GRC
Start Date
2022-11-29
Trial ID
NCT05798715
Treatments Being Tested
This study aims to demonstrate the bioequivalence between the formulation o...
Status
Completed
Location
Farmagen IKU Merkezi
Start Date
2024-08-13
Trial ID
NCT06595121
Treatments Being Tested
The goal of this study is to determine whether two new, non-X-ray technique...
Status
Terminated
Location
Vanderbilt Univeristy Medical Center
Start Date
2015-06-30
Trial ID
NCT02436356
Treatments Being Tested
The clinical protocol of the clinical testing of this device: 1. Objective...
Status
Completed
Location
Zhongshan City People's Hospital
Start Date
2011-02
Trial ID
NCT01440894
Treatments Being Tested
A study demonstrates the bioequivalence of DA-1229\_01(A) at Fasting State ...
Status
Completed
Location
Metro Hospital
Start Date
2019-02-07
Trial ID
NCT03939143
Treatments Being Tested